ID   DQA1_HUMAN              Reviewed;         254 AA.
AC   P01909; O19630; O19706; P01907; P01908; P04225; P04226; P05536; P79553;
AC   Q06751; Q29876; Q29994; Q2Q6Y6; Q2Q6Y7; Q2Q6Y8; Q2WCM3; Q30064; Q30067;
AC   Q30068; Q30070; Q30071; Q30072; Q30073; Q30086; Q30101; Q5Y7D5; Q5Y7F5;
AC   Q6ICU6; Q6PR46; Q6QDB1; Q860W2; Q860W4; Q9BD37; Q9TPM3; Q9UM31;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   28-JAN-2026, entry version 218.
DE   RecName: Full=HLA class II histocompatibility antigen, DQ alpha 1 chain;
DE   AltName: Full=DC-1 alpha chain;
DE   AltName: Full=DC-alpha;
DE   AltName: Full=HLA-DCA;
DE   AltName: Full=MHC class II DQA1;
DE   Flags: Precursor;
GN   Name=HLA-DQA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*02:01).
RX   PubMed=6415485; DOI=10.1038/305813a0;
RA   Chang H.-C., Moriuchi T., Silver J.;
RT   "The heavy chain of human B-cell alloantigen HLA-DS has a variable N-
RT   terminal region and a constant immunoglobulin-like region.";
RL   Nature 305:813-815(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01).
RX   PubMed=6585297; DOI=10.1002/j.1460-2075.1984.tb01826.x;
RA   Schenning L., Larhammar D., Bill P., Wiman K., Jonsson A.-K., Rask L.,
RA   Peterson P.A.;
RT   "Both alpha and beta chains of HLA-DC class II histocompatibility antigens
RT   display extensive polymorphism in their amino-terminal domains.";
RL   EMBO J. 3:447-452(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES DQA1*01:02 AND ALLELE DQA1*03:01).
RX   PubMed=6584734; DOI=10.1038/308327a0;
RA   Auffray C., Lillie J.W., Arnot D., Grossberger D., Kappes D.,
RA   Strominger J.L.;
RT   "Isotypic and allotypic variation of human class II histocompatibility
RT   antigen alpha-chain genes.";
RL   Nature 308:327-333(1984).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01).
RX   PubMed=3584986;
RA   Schiffenbauer J., Didier D.K., Klearman M., Rice K., Shuman S.,
RA   Tieber V.L., Kittlesen D.J., Schwartz B.D.;
RT   "Complete sequence of the HLA DQ alpha and DQ beta cDNA from a DR5/DQw3
RT   cell line.";
RL   J. Immunol. 139:228-233(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*05:01).
RX   PubMed=9271631; DOI=10.1007/s002510050295;
RA   Ellis M.C., Hetisimer A.H., Ruddy D.A., Hansen S.L., Kronmal G.S.,
RA   McClelland E., Quintana L., Drayna D.T., Aldrich M.S., Mignot E.;
RT   "HLA class II haplotype and sequence analysis support a role for DQ in
RT   narcolepsy.";
RL   Immunogenetics 46:410-417(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:01; DQA1*01:02 AND
RP   DQA1*03:01).
RX   PubMed=16140993; DOI=10.1101/gr.3554305;
RA   Raymond C.K., Kas A., Paddock M., Qiu R., Zhou Y., Subramanian S.,
RA   Chang J., Palmieri A., Haugen E., Kaul R., Olson M.V.;
RT   "Ancient haplotypes of the HLA Class II region.";
RL   Genome Res. 15:1250-1257(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02; DQA1*05:06;
RP   DQA1*05:07 AND DQA1*05:08).
RX   PubMed=16866887; DOI=10.1111/j.1399-0039.2006.00645.x;
RA   Lee K.W., Jung Y.A., Oh D.H.;
RT   "Four novel human leukocyte antigen-DQA1 alleles identified in the Korean
RT   population.";
RL   Tissue Antigens 68:167-172(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*03:01).
RX   PubMed=3036828; DOI=10.1016/s0021-9258(18)47482-0;
RA   Jonsson A.-K., Hyldig-Nielsen J.-J., Servenius B., Larhammar D.,
RA   Andersson G., Joergensen F., Peterson P.A., Rask L.;
RT   "Class II genes of the human major histocompatibility complex. Comparisons
RT   of the DQ and DX alpha and beta genes.";
RL   J. Biol. Chem. 262:8767-8777(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*01:01).
RA   Ashdown M.L., Leas L., Gavrilidis A., Wood J.M., Simons M.J.;
RT   "Identification of a novel DQA1 allele, DQA1*01012, and confirmatory
RT   sequence of DQA1*01011.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*02:01).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02 AND DQA1*05:09).
RA   Voorter C.E., van den Berg-Loonen E.M.;
RT   "New and confirmatory HLA sequences by SBT.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*01:01).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELES DQA1*01:02;
RP   DQA1*03:01 AND DQA1*05:01).
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELES DQA1*03:01 AND DQA1*05:01).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-27 (ALLELES
RP   DQA1*01:01/DQA1*01:02/DQA1*01:03; DQA1*01:04; DQA1*01:05;
RP   DQA1*02:01/DQA1*03:01/DQA1*03:03; DQA1*04:01/DQA1*06:01 AND
RP   DQA1*05:01/DQA1*05:03/DQA1*05:05).
RC   TISSUE=B-cell;
RA   Yasunaga S., Kimura A., Sasazuki T.;
RT   "Sequence polymorphisms in HLA-DQA1 exon1.";
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-254 (ALLELE DQA1*03:02).
RX   PubMed=3879967; DOI=10.1073/pnas.82.10.3420;
RA   Moriuchi J., Moriuchi T., Silver J.;
RT   "Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell
RT   line: genetic and evolutionary implications.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3420-3424(1985).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 23-254 (ALLELE DQA1*01:02).
RX   PubMed=3259543; DOI=10.1007/bf00364432;
RA   Lock C.B., So A.K., Welsh K.I., Parkes J.D., Trowsdale J.;
RT   "MHC class II sequences of an HLA-DR2 narcoleptic.";
RL   Immunogenetics 27:449-455(1988).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-250 (ALLELE DQA1*03:02/DQA1*03:03) AND
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELES DQA1*01:01; DQA1*01:03;
RP   DQA1*01:04; DQA1*04:01; DQA1*05:03; DQA1*05:05 AND DQA1*06:01).
RX   PubMed=8929711; DOI=10.1111/j.1399-0039.1996.tb02512.x;
RA   Yasunaga S., Kimura A., Hamaguchi K., Ronningen K.S., Sasazuki T.;
RT   "Different contribution of HLA-DR and -DQ genes in susceptibility and
RT   resistance to insulin-dependent diabetes mellitus (IDDM).";
RL   Tissue Antigens 47:37-48(1996).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELE DQA1*01:05).
RA   Yasunaga S.;
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [20]
RP   PROTEIN SEQUENCE OF 24-89; 102-120 AND 164-212 (ALLELE DQA1*01:02).
RX   PubMed=6576979; DOI=10.1515/bchm2.1983.364.1.749;
RA   Goetz H., Kratzin H., Thinnes F.P., Yang C.-Y., Kruse T., Pauly E.,
RA   Koelbel S., Egert G., Wernet P., Hilschmann N.;
RT   "Primary structure of human class II histocompatibility antigens 3rd
RT   communication. Amino acid sequence comparison between DR and DC subclass
RT   antigens derived from a lymphoblastoid B cell line homozygous at the HLA
RT   loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1).";
RL   Hoppe-Seyler's Z. Physiol. Chem. 364:749-755(1983).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-209 (ALLELE DQA1*05:01).
RX   PubMed=2493052;
RA   Kao H.T., Gregersen P.K., Tang J.C., Takahashi T., Wang C.Y., Silver J.;
RT   "Molecular analysis of the HLA class II genes in two DRw6-related
RT   haplotypes, DRw13 DQw1 and DRw14 DQw3.";
RL   J. Immunol. 142:1743-1747(1989).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELES DQA1*04:02 AND
RP   DQA1*04:04).
RX   PubMed=15853899; DOI=10.1111/j.1399-0039.2005.00389.x;
RA   Cordovado S.K., Hancock L.N., Simone A.E., Hendrix M., Mueller P.W.;
RT   "High-resolution genotyping of HLA-DQA1 in the GoKinD study and
RT   identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-
RT   DQA1*0404.";
RL   Tissue Antigens 65:448-458(2005).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*06:02).
RA   Simone A.E., Cordovado S.K., Hendrix M.M., Mueller P.W.;
RT   "Identification of a novel HLA-DQA1*06 allele detected by sequence-based
RT   typing.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [24]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*01:07).
RA   Hancock L.N., Cordovado S.K., Mueller P.W.;
RT   "Identification of a novel HLA-DQA1*01 allele detected by sequence-based
RT   typing.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [25]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-110 (ALLELE DQA1*01:02), AND
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE DQA1*05:01).
RX   PubMed=3372263; DOI=10.1016/0198-8859(88)90034-1;
RA   Horn G.T., Bugawan T.L., Long C.M., Manos M.M., Erlich H.A.;
RT   "Sequence analysis of HLA class II genes from insulin-dependent diabetic
RT   individuals.";
RL   Hum. Immunol. 21:249-263(1988).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE DQA1*05:04).
RA   Trejaut J.A., Greville W.D., Dunckley H.;
RT   "DQA1 subtyping in Australian Aborigines. Additional evidence for
RT   heterogeneity.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [27]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 31-109 (ALLELE DQA1*01:06).
RX   PubMed=10395113; DOI=10.1034/j.1399-0039.1999.530613.x;
RA   Luo M., Blanchard J., Maclean I., Brunham R.;
RT   "Identification of a novel HLA-DQA1 allele (DQA1*0106) by sequence-based
RT   DQA1 typing.";
RL   Tissue Antigens 53:595-596(1999).
RN   [28]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-74 (ALLELE DQA1*05:02).
RX   PubMed=1362295; DOI=10.1111/j.1399-0039.1992.tb02050.x;
RA   Marsh S.G., Bodomer J.G.;
RT   "HLA class II nucleotide sequences, 1992.";
RL   Tissue Antigens 40:229-243(1992).
RN   [29]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-254 (ALLELE DQA1*05:01).
RX   PubMed=3129499;
RA   Liu C.P., Bach F.H., Wu S.K.;
RT   "Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype.
RT   Multiple genetic mechanisms in the generation of polymorphic HLA class II
RT   genes.";
RL   J. Immunol. 140:3631-3639(1988).
RN   [30]
RP   ERRATUM OF PUBMED:3129499.
RA   Liu C.P., Bach F.H., Wu S.K.;
RL   J. Immunol. 144:15441-15441(1990).
RN   [31]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 40-254 (ALLELE DQA1*03:01).
RX   PubMed=6815651; DOI=10.1073/pnas.79.20.6337;
RA   Auffray C., Korman A.J., Roux-Dosseto M., Bono R., Strominger J.L.;
RT   "cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong
RT   sequence homology to the HLA-DR heavy chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:6337-6341(1982).
RN   [32]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-102 (ALLELE DQA1*05:01), AND
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-103 (ALLELE DQA1*01:02).
RX   PubMed=2513578; DOI=10.1073/pnas.86.24.9986;
RA   Gyllensten U.B., Erlich H.A.;
RT   "Ancient roots for polymorphism at the HLA-DQ alpha locus in primates.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:9986-9990(1989).
RN   [33]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 119-254 (ALLELE DQA1*01:02).
RX   PubMed=2888727; DOI=10.1007/bf00346523;
RA   Turco E., Care A., Compagnone-Post P., Robinson C., Cascino I., Trucco M.;
RT   "Allelic forms of the alpha- and beta-chain genes encoding DQw1-positive
RT   heterodimers.";
RL   Immunogenetics 26:282-290(1987).
RN   [34]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/s0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [35]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/s0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most out
RT   of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [36]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [37]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [38]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [39]
RP   REVIEW.
RX   PubMed=19533806; DOI=10.3748/wjg.15.2855;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 27-207 OF HLA-DQA1/HLA-DQB1
RP   HETERODIMER IN COMPLEX WITH INS PEPTIDE, SUBUNIT, GLYCOSYLATION AT ASN-103,
RP   AND DISULFIDE BOND.
RX   PubMed=11376336; DOI=10.1038/88694;
RA   Lee K.H., Wucherpfennig K.W., Wiley D.C.;
RT   "Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to
RT   type 1 diabetes.";
RL   Nat. Immunol. 2:501-507(2001).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 24-219 OF HLA-DQA1/HLA-DQB1
RP   HETERODIMER (HLA-DQ0602) IN COMPLEX WITH HCRT PEPTIDE, POLYMORPHISM,
RP   SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=14769912; DOI=10.1073/pnas.0308458100;
RA   Siebold C., Hansen B.E., Wyer J.R., Harlos K., Esnouf R.E., Svejgaard A.,
RA   Bell J.I., Strominger J.L., Jones E.Y., Fugger L.;
RT   "Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and
RT   confers strong susceptibility to narcolepsy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:1999-2004(2004).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.22 ANGSTROMS) OF 24-216 OF HLA-DQA1/HLA-DQB1
RP   HETERODIMER (DQ2) IN COMPLEX WITH TRITICUM AESTIVUM ALPHA/BETA-GLIADIN
RP   PEPTIDE, SUBUNIT, AND POLYMORPHISM.
RX   PubMed=15020763; DOI=10.1073/pnas.0306885101;
RA   Kim C.Y., Quarsten H., Bergseng E., Khosla C., Sollid L.M.;
RT   "Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in
RT   celiac disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:4175-4179(2004).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 24-206 OF HLA-DQA1/HLA-DQB1
RP   HETERODIMER IN COMPLEX WITH TRITICUM AESTIVUM ALPHA/BETA-GLIADIN, SUBUNIT,
RP   AND DISULFIDE BOND.
RX   PubMed=17629515; DOI=10.1016/j.immuni.2007.05.015;
RA   Henderson K.N., Tye-Din J.A., Reid H.H., Chen Z., Borg N.A., Beissbarth T.,
RA   Tatham A., Mannering S.I., Purcell A.W., Dudek N.L., van Heel D.A.,
RA   McCluskey J., Rossjohn J., Anderson R.P.;
RT   "A structural and immunological basis for the role of human leukocyte
RT   antigen DQ8 in celiac disease.";
RL   Immunity 27:23-34(2007).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents them on
CC       the cell surface for recognition by the CD4 T-cells. The peptide
CC       binding cleft accommodates peptides of 10-30 residues. The peptides
CC       presented by MHC class II molecules are generated mostly by degradation
CC       of proteins that access the endocytic route, where they are processed
CC       by lysosomal proteases and other hydrolases. Exogenous antigens that
CC       have been endocytosed by the APC are thus readily available for
CC       presentation via MHC II molecules, and for this reason this antigen
CC       presentation pathway is usually referred to as exogenous. As membrane
CC       proteins on their way to degradation in lysosomes as part of their
CC       normal turn-over are also contained in the endosomal/lysosomal
CC       compartments, exogenous antigens must compete with those derived from
CC       endogenous components. Autophagy is also a source of endogenous
CC       peptides, autophagosomes constitutively fuse with MHC class II loading
CC       compartments. In addition to APCs, other cells of the gastrointestinal
CC       tract, such as epithelial cells, express MHC class II molecules and
CC       CD74 and act as APCs, which is an unusual trait of the GI tract. To
CC       produce a MHC class II molecule that presents an antigen, three MHC
CC       class II molecules (heterodimers of an alpha and a beta chain)
CC       associate with a CD74 trimer in the ER to form a heterononamer. Soon
CC       after the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs, CD74 undergoes a sequential
CC       degradation by various proteases, including CTSS and CTSL, leaving a
CC       small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM
CC       stabilizes MHC class II molecules until primary high affinity antigenic
CC       peptides are bound. The MHC II molecule bound to a peptide is then
CC       transported to the cell membrane surface. In B-cells, the interaction
CC       between HLA-DM and MHC class II molecules is regulated by HLA-DO.
CC       Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal
CC       microenvironment has been implicated in the regulation of antigen
CC       loading into MHC II molecules, increased acidification produces
CC       increased proteolysis and efficient peptide loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred as
CC       MHC class II molecule. In the endoplasmic reticulum (ER) it forms a
CC       heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also
CC       known as invariant chain or HLA class II histocompatibility antigen
CC       gamma chain). In the endosomal/lysosomal system; CD74 undergoes
CC       sequential degradation by various proteases; leaving a small fragment
CC       termed CLIP on each MHC class II molecule. MHC class II molecule
CC       interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP
CC       and facilitate the binding of antigenic peptides.
CC       {ECO:0000269|PubMed:11376336, ECO:0000269|PubMed:14769912,
CC       ECO:0000269|PubMed:15020763, ECO:0000269|PubMed:17629515}.
CC   -!- INTERACTION:
CC       P01909; P01920: HLA-DQB1; NbExp=10; IntAct=EBI-713389, EBI-1038012;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I membrane
CC       protein. Golgi apparatus, trans-Golgi network membrane; Single-pass
CC       type I membrane protein. Endosome membrane; Single-pass type I membrane
CC       protein. Lysosome membrane; Single-pass type I membrane protein.
CC       Note=The MHC class II complex transits through a number of
CC       intracellular compartments in the endocytic pathway until it reaches
CC       the cell membrane for antigen presentation.
CC   -!- POLYMORPHISM: The following alleles of DQA1 are known: DQA1*01:01,
CC       DQA1*01:02, DQA1*01:03, DQA1*01:04, DQA1*01:05, DQA1*01:06, DQA1*01:07,
CC       DQA1*02:01, DQA1*03:01, DQA1*03:02, DQA1*03:03, DQA1*04:01, DQA1*04:02,
CC       DQA1*04:03, DQA1*04:04, DQA1*05:01, DQA1*05:02, DQA1*05:03, DQA1*05:04,
CC       DQA1*05:05, DQA1*05:06, DQA1*05:07, DQA1*05:08, DQA1*05:09, DQA1*06:01,
CC       DQA1*06:02. The sequence shown is that of DQA1*05:01.
CC   -!- POLYMORPHISM: DQ2 (heterodimer of DQA1*05:01/DQB1*02:01) is associated
CC       with more than 90% of celiac disease patients. A minority displays DQ8
CC       (heterodimer of DQA1*03/DQB1*03:02). DQ0602 (heterodimer of
CC       DQA1*01:02/DQB1*06:02) confers dominant protection against type 1
CC       diabetes (T1D) and strong susceptibility to narcolepsy.
CC   -!- SIMILARITY: Belongs to the MHC class II family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD56720.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00033; CAA24917.1; -; mRNA.
DR   EMBL; X00370; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; X00452; CAA25141.1; -; mRNA.
DR   EMBL; M16995; AAA59760.1; -; mRNA.
DR   EMBL; U92032; AAB91990.1; -; Genomic_DNA.
DR   EMBL; AY663395; AAU87978.1; -; Genomic_DNA.
DR   EMBL; AY663398; AAU87987.1; -; Genomic_DNA.
DR   EMBL; AY663400; AAU87992.1; -; Genomic_DNA.
DR   EMBL; AY663406; AAU88007.1; -; Genomic_DNA.
DR   EMBL; AY663411; AAU88022.1; -; Genomic_DNA.
DR   EMBL; AY663413; AAU88028.1; -; Genomic_DNA.
DR   EMBL; DQ178403; ABA86855.1; -; Genomic_DNA.
DR   EMBL; DQ178400; ABA86855.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178401; ABA86855.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178402; ABA86855.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178407; ABA86856.1; -; Genomic_DNA.
DR   EMBL; DQ178404; ABA86856.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178405; ABA86856.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178406; ABA86856.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178411; ABA86857.1; -; Genomic_DNA.
DR   EMBL; DQ178408; ABA86857.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178409; ABA86857.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178410; ABA86857.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178415; ABA86858.1; -; Genomic_DNA.
DR   EMBL; DQ178412; ABA86858.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178413; ABA86858.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178414; ABA86858.1; JOINED; Genomic_DNA.
DR   EMBL; M29616; AAA59759.1; -; Genomic_DNA.
DR   EMBL; M29613; AAA59759.1; JOINED; Genomic_DNA.
DR   EMBL; AF322870; AAK11577.1; -; Genomic_DNA.
DR   EMBL; AF322867; AAK11577.1; JOINED; Genomic_DNA.
DR   EMBL; AF322868; AAK11577.1; JOINED; Genomic_DNA.
DR   EMBL; AF322869; AAK11577.1; JOINED; Genomic_DNA.
DR   EMBL; AF395700; AAM69677.1; -; Genomic_DNA.
DR   EMBL; AF395697; AAM69677.1; JOINED; Genomic_DNA.
DR   EMBL; AF395698; AAM69677.1; JOINED; Genomic_DNA.
DR   EMBL; AF395699; AAM69677.1; JOINED; Genomic_DNA.
DR   EMBL; CR450297; CAG29293.1; -; mRNA.
DR   EMBL; AM042559; CAJ14960.1; -; Genomic_DNA.
DR   EMBL; AM042560; CAJ14961.1; -; Genomic_DNA.
DR   EMBL; AK313975; BAG36689.1; -; mRNA.
DR   EMBL; BX248406; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662789; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84489; CAB06491.1; -; Genomic_DNA.
DR   EMBL; BC008585; AAH08585.1; -; mRNA.
DR   EMBL; BC157865; AAI57866.1; -; mRNA.
DR   EMBL; L46875; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46876; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46877; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46878; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46880; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46881; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M11124; AAA59754.1; -; mRNA.
DR   EMBL; M20431; AAA59758.1; -; mRNA.
DR   EMBL; L34082; AAC41950.1; -; mRNA.
DR   EMBL; L34085; AAC41953.1; -; mRNA.
DR   EMBL; L34086; AAC41954.1; -; mRNA.
DR   EMBL; L34089; AAC41957.1; -; mRNA.
DR   EMBL; L34090; AAC41958.1; -; mRNA.
DR   EMBL; L34092; AAC41960.1; -; mRNA.
DR   EMBL; L34093; AAC41961.1; -; mRNA.
DR   EMBL; L34094; AAC41962.1; -; mRNA.
DR   EMBL; L42625; AAA85334.1; -; mRNA.
DR   EMBL; AY197775; AAO45622.1; -; Genomic_DNA.
DR   EMBL; AY547314; AAS49496.1; -; Genomic_DNA.
DR   EMBL; AY206406; AAO47362.1; -; Genomic_DNA.
DR   EMBL; AY585236; AAT09985.1; -; Genomic_DNA.
DR   EMBL; M34997; AAA35772.1; -; Genomic_DNA.
DR   EMBL; M34999; AAA74633.1; -; Genomic_DNA.
DR   EMBL; U85035; AAB41891.1; -; Genomic_DNA.
DR   EMBL; AF109734; AAD56720.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U03675; AAB60341.1; -; Genomic_DNA.
DR   EMBL; M20506; AAA59774.1; -; mRNA.
DR   EMBL; J00199; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M17846; AAA59707.1; -; mRNA.
DR   PIR; A02211; HLHUD1.
DR   PIR; A02213; HLHUDQ.
DR   PIR; A02214; HLHUD7.
DR   PIR; A02215; HLHU3C.
DR   PIR; A93326; HLHUDC.
DR   PIR; B27628; B27628.
DR   PIR; D34512; D34512.
DR   RefSeq; NP_002113.2; NM_002122.3.
DR   RefSeq; XP_054185776.1; XM_054329801.1.
DR   RefSeq; XP_054185777.1; XM_054329802.1.
DR   RefSeq; XP_054187030.1; XM_054331055.1.
DR   RefSeq; XP_054187031.1; XM_054331056.1.
DR   PDB; 1JK8; X-ray; 2.40 A; A=27-206.
DR   PDB; 1S9V; X-ray; 2.22 A; A/D=24-216.
DR   PDB; 1UVQ; X-ray; 1.80 A; A=24-218.
DR   PDB; 2NNA; X-ray; 2.10 A; A=24-206.
DR   PDB; 4GG6; X-ray; 3.20 A; A/C=24-206.
DR   PDB; 4OZF; X-ray; 2.70 A; A=24-206.
DR   PDB; 4OZG; X-ray; 3.00 A; A/C=24-206.
DR   PDB; 4OZH; X-ray; 2.80 A; A/C=24-206.
DR   PDB; 4OZI; X-ray; 3.20 A; A/C=24-206.
DR   PDB; 5KSA; X-ray; 2.00 A; A=24-206.
DR   PDB; 5KSB; X-ray; 2.90 A; A/C=24-206.
DR   PDB; 5KSU; X-ray; 2.73 A; A/D=24-216.
DR   PDB; 5KSV; X-ray; 2.19 A; A=24-216.
DR   PDB; 6MFF; X-ray; 2.60 A; A=24-206.
DR   PDB; 6MFG; X-ray; 2.00 A; A/C=24-206.
DR   PDB; 6U3M; X-ray; 1.90 A; A/C=24-206.
DR   PDB; 6U3N; X-ray; 2.80 A; A=24-206.
DR   PDB; 6XP6; X-ray; 2.40 A; A/D=24-206.
DR   PDB; 7SG0; X-ray; 3.00 A; A=24-206.
DR   PDB; 7SG1; X-ray; 3.10 A; A/F=24-206.
DR   PDB; 7SG2; X-ray; 3.10 A; A/F=24-206.
DR   PDB; 8VSP; EM; 3.12 A; A/D/G=1-254.
DR   PDB; 8W83; X-ray; 2.82 A; C/G/K/O=24-206.
DR   PDB; 8W84; X-ray; 2.10 A; C=24-206.
DR   PDB; 8W85; X-ray; 2.77 A; C/G=24-206.
DR   PDB; 8W86; X-ray; 2.24 A; C/G=24-206.
DR   PDB; 9EJG; X-ray; 2.20 A; A=24-206.
DR   PDB; 9EJH; X-ray; 2.45 A; A=24-206.
DR   PDBsum; 1JK8; -.
DR   PDBsum; 1S9V; -.
DR   PDBsum; 1UVQ; -.
DR   PDBsum; 2NNA; -.
DR   PDBsum; 4GG6; -.
DR   PDBsum; 4OZF; -.
DR   PDBsum; 4OZG; -.
DR   PDBsum; 4OZH; -.
DR   PDBsum; 4OZI; -.
DR   PDBsum; 5KSA; -.
DR   PDBsum; 5KSB; -.
DR   PDBsum; 5KSU; -.
DR   PDBsum; 5KSV; -.
DR   PDBsum; 6MFF; -.
DR   PDBsum; 6MFG; -.
DR   PDBsum; 6U3M; -.
DR   PDBsum; 6U3N; -.
DR   PDBsum; 6XP6; -.
DR   PDBsum; 7SG0; -.
DR   PDBsum; 7SG1; -.
DR   PDBsum; 7SG2; -.
DR   PDBsum; 8VSP; -.
DR   PDBsum; 8W83; -.
DR   PDBsum; 8W84; -.
DR   PDBsum; 8W85; -.
DR   PDBsum; 8W86; -.
DR   PDBsum; 9EJG; -.
DR   PDBsum; 9EJH; -.
DR   AlphaFoldDB; P01909; -.
DR   EMDB; EMD-43501; -.
DR   SMR; P01909; -.
DR   BioGRID; 109362; 154.
DR   BioGRID; 1529240; 5.
DR   FunCoup; P01909; 465.
DR   IntAct; P01909; 129.
DR   MINT; P01909; -.
DR   ChEMBL; CHEMBL4105884; -.
DR   TCDB; 9.A.75.1.1; the mhc ii receptor (mhc2r) family.
DR   GlyConnect; 1986; 2 N-Linked glycans (1 site).
DR   GlyCosmos; P01909; 2 sites, 2 glycans.
DR   GlyGen; P01909; 4 sites, 2 N-linked glycans (1 site).
DR   iPTMnet; P01909; -.
DR   BioMuta; HLA-DQA1; -.
DR   DMDM; 122188; -.
DR   jPOST; P01909; -.
DR   MassIVE; P01909; -.
DR   PeptideAtlas; P01909; -.
DR   ProteomicsDB; 51510; -.
DR   ABCD; P01909; 24 sequenced antibodies.
DR   Antibodypedia; 2728; 687 antibodies from 39 providers.
DR   CPTC; P01909; 2 antibodies.
DR   DNASU; 3117; -.
DR   Ensembl; ENST00000343139.11; ENSP00000339398.5; ENSG00000196735.14.
DR   Ensembl; ENST00000374949.2; ENSP00000364087.2; ENSG00000196735.14.
DR   Ensembl; ENST00000383251.6; ENSP00000372738.2; ENSG00000206305.12.
DR   Ensembl; ENST00000395363.5; ENSP00000378767.1; ENSG00000196735.14.
DR   Ensembl; ENST00000399675.5; ENSP00000382583.1; ENSG00000206305.12.
DR   Ensembl; ENST00000399678.5; ENSP00000382586.1; ENSG00000206305.12.
DR   Ensembl; ENST00000418023.5; ENSP00000387892.1; ENSG00000232062.9.
DR   Ensembl; ENST00000444296.6; ENSP00000413237.2; ENSG00000232062.9.
DR   GeneID; 3117; -.
DR   KEGG; hsa:3117; -.
DR   MANE-Select; ENST00000343139.11; ENSP00000339398.5; NM_002122.5; NP_002113.2.
DR   UCSC; uc003obr.4; human.
DR   AGR; HGNC:4942; -.
DR   ClinPGx; PA35066; -.
DR   CTD; 3117; -.
DR   DisGeNET; 3117; -.
DR   GeneCards; HLA-DQA1; -.
DR   GeneReviews; HLA-DQA1; -.
DR   HGNC; HGNC:4942; HLA-DQA1.
DR   HPA; ENSG00000196735; Tissue enhanced (lung, lymphoid tissue).
DR   MalaCards; HLA-DQA1; -.
DR   MIM; 146880; gene.
DR   NIAGADS; ENSG00000196735; -.
DR   OpenTargets; ENSG00000196735; -.
DR   Orphanet; 391490; Adult-onset myasthenia gravis.
DR   Orphanet; 930; Idiopathic achalasia.
DR   VEuPathDB; HostDB:ENSG00000196735; -.
DR   GeneTree; ENSGT00940000162892; -.
DR   HOGENOM; CLU_069380_0_0_1; -.
DR   InParanoid; P01909; -.
DR   PAN-GO; P01909; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; P01909; -.
DR   PathwayCommons; P01909; -.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-202427; Phosphorylation of CD3 and TCR zeta chains.
DR   Reactome; R-HSA-202430; Translocation of ZAP-70 to Immunological synapse.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-389948; Co-inhibition by PD-1.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   SignaLink; P01909; -.
DR   SIGNOR; P01909; -.
DR   Agora; ENSG00000196735; -.
DR   BioGRID-ORCS; 3117; 7 hits in 1073 CRISPR screens.
DR   ChiTaRS; HLA-DQA1; human.
DR   EvolutionaryTrace; P01909; -.
DR   GenomeRNAi; 3117; -.
DR   Pharos; P01909; Tbio.
DR   PRO; PR:P01909; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P01909; protein.
DR   Bgee; ENSG00000196735; Expressed in gall bladder and 162 other cell types or tissues.
DR   ExpressionAtlas; P01909; baseline and differential.
DR   GO; GO:0030669; C:clathrin-coated endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0031902; C:late endosome membrane; IBA:GO_Central.
DR   GO; GO:0098553; C:lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; ISS:CAFA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0030658; C:transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0023026; F:MHC class II protein complex binding; IBA:GO_Central.
DR   GO; GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:CAFA.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IBA:GO_Central.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0002503; P:peptide antigen assembly with MHC class II protein complex; IBA:GO_Central.
DR   GO; GO:0050778; P:positive regulation of immune response; IBA:GO_Central.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IBA:GO_Central.
DR   CDD; cd21008; IgC1_MHC_II_alpha_HLA-DQ; 1.
DR   FunFam; 2.60.40.10:FF:000280; HLA class II histocompatibility antigen, DR alpha chain; 1.
DR   FunFam; 3.10.320.10:FF:000002; HLA class II histocompatibility antigen, DR alpha chain; 1.
DR   Gene3D; 3.10.320.10; Class II Histocompatibility Antigen, M Beta Chain, Chain B, domain 1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR050160; MHC/Immunoglobulin.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR001003; MHC_II_a_N.
DR   PANTHER; PTHR19944:SF59; HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DQ ALPHA 1 CHAIN; 1.
DR   PANTHER; PTHR19944; MHC CLASS II-RELATED; 1.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00993; MHC_II_alpha; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00920; MHC_II_alpha; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   SUPFAM; SSF54452; MHC antigen-recognition domain; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; Endoplasmic reticulum; Endosome; Glycoprotein;
KW   Golgi apparatus; Immunity; Lysosome; Membrane; MHC II;
KW   Proteomics identification; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:6576979"
FT   CHAIN           24..254
FT                   /note="HLA class II histocompatibility antigen, DQ alpha 1
FT                   chain"
FT                   /id="PRO_0000018970"
FT   TOPO_DOM        24..216
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        217..239
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        240..254
FT                   /note="Cytoplasmic"
FT   DOMAIN          112..204
FT                   /note="Ig-like C1-type"
FT   REGION          24..119
FT                   /note="Alpha-1"
FT   REGION          120..203
FT                   /note="Alpha-2"
FT   REGION          204..216
FT                   /note="Connecting peptide"
FT   CARBOHYD        103
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        143
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        132..188
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:11376336, ECO:0000269|PubMed:14769912,
FT                   ECO:0000269|PubMed:17629515"
FT   VARIANT         8
FT                   /note="M -> L (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*04:01 and allele DQA1*06:01; dbSNP:rs1047989)"
FT                   /id="VAR_033399"
FT   VARIANT         11
FT                   /note="A -> T (in allele DQA1*05:05, allele DQA1*05:08 and
FT                   allele DQA1*05:09; dbSNP:rs1047992)"
FT                   /id="VAR_033400"
FT   VARIANT         17
FT                   /note="V -> M (in allele DQA1*01:04 and allele DQA1*01:05;
FT                   dbSNP:rs12722039)"
FT                   /id="VAR_050380"
FT   VARIANT         18
FT                   /note="M -> T (in allele DQA1*03:03; dbSNP:rs11545686)"
FT                   /id="VAR_050381"
FT   VARIANT         24
FT                   /note="E -> K (in allele DQA1*05:09; dbSNP:rs41545012)"
FT                   /id="VAR_060493"
FT   VARIANT         25
FT                   /note="D -> G (in allele DQA1*01:04 and allele DQA1*01:05;
FT                   dbSNP:rs12722042)"
FT                   /id="VAR_050382"
FT   VARIANT         34
FT                   /note="Y -> C (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1129740)"
FT                   /id="VAR_060494"
FT   VARIANT         41
FT                   /note="S -> F (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1071630)"
FT                   /id="VAR_033401"
FT   VARIANT         44
FT                   /note="P -> L (in allele DQA1*05:04; dbSNP:rs41549715)"
FT                   /id="VAR_060495"
FT   VARIANT         48
FT                   /note="Y -> F (in allele DQA1*02:01, allele DQA1*01:03,
FT                   allele DQA1*06:01 and allele DQA1*06:02; dbSNP:rs12722051)"
FT                   /id="VAR_033402"
FT   VARIANT         49
FT                   /note="T -> S (in allele DQA1*03:01, allele DQA1*03:02 and
FT                   allele DQA1*03:03; dbSNP:rs1048023)"
FT                   /id="VAR_033403"
FT   VARIANT         57
FT                   /note="Q -> E (in allele DQA1*01:01, allele DQA1*01:04,
FT                   allele DQA1*01:05, allele DQA1*01:07, allele DQA1*02:01,
FT                   allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03;
FT                   dbSNP:rs10093)"
FT                   /id="VAR_014604"
FT   VARIANT         63
FT                   /note="G -> E (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,
FT                   allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03;
FT                   dbSNP:rs1142323)"
FT                   /id="VAR_060496"
FT   VARIANT         64
FT                   /note="R -> K (in allele DQA1*01:03; dbSNP:rs36219699)"
FT                   /id="VAR_050383"
FT   VARIANT         67
FT                   /note="T -> A (in allele DQA1*01:06; dbSNP:rs41543221)"
FT                   /id="VAR_060497"
FT   VARIANT         68
FT                   /note="V -> A (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142324)"
FT                   /id="VAR_060498"
FT   VARIANT         70
FT                   /note="C -> K (in allele DQA1*02:01; requires 2 nucleotide
FT                   substitutions)"
FT                   /id="VAR_060499"
FT   VARIANT         70
FT                   /note="C -> Q (in allele DQA1*03:01, allele DQA1*03:02 and
FT                   allele DQA1*03:03; requires 2 nucleotide substitutions)"
FT                   /id="VAR_060500"
FT   VARIANT         70
FT                   /note="C -> R (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142326)"
FT                   /id="VAR_060501"
FT   VARIANT         70
FT                   /note="C -> Y (in dbSNP:rs3207983)"
FT                   /id="VAR_033404"
FT   VARIANT         71
FT                   /note="L -> W (in allele DQA1*01:01, allele
FT                   DQA1*01:02,allele DQA1*01:03, allele DQA1*01:04, allele
FT                   DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07;
FT                   dbSNP:rs1142328)"
FT                   /id="VAR_060502"
FT   VARIANT         73
FT                   /note="V -> D (in dbSNP:rs760671632)"
FT                   /id="VAR_033406"
FT   VARIANT         73
FT                   /note="V -> E (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs3208105)"
FT                   /id="VAR_060503"
FT   VARIANT         73
FT                   /note="V -> L (in allele DQA1*02:01, allele DQA1*03:01,
FT                   allele DQA1*03:02 and allele DQA1*03:03; dbSNP:rs12722061)"
FT                   /id="VAR_033405"
FT   VARIANT         74
FT                   /note="L -> F (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,
FT                   allele DQA1*03:01, allele DQA1*03:02 and allele DQA1*03:03;
FT                   dbSNP:rs9272698)"
FT                   /id="VAR_060504"
FT   VARIANT         75
FT                   /note="R -> H (in allele DQA1*02:01; dbSNP:rs28383449)"
FT                   /id="VAR_060505"
FT   VARIANT         75
FT                   /note="R -> S (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs9272699)"
FT                   /id="VAR_060506"
FT   VARIANT         76
FT                   /note="Q -> K (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1048052)"
FT                   /id="VAR_060507"
FT   VARIANT         76
FT                   /note="Q -> R (in allele DQA1*02:01, allele DQA1*03:01,
FT                   allele DQA1*03:02 and allele DQA1*03:03; dbSNP:rs12722069)"
FT                   /id="VAR_060508"
FT   VARIANT         77
FT                   /note="F -> L (in allele DQA1*02:01; dbSNP:rs3188043)"
FT                   /id="VAR_060509"
FT   VARIANT         78
FT                   /note="R -> GG (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele
FT                   DQA1*01:05,allele DQA1*01:06 and allele DQA1*01:07;
FT                   dbSNP:rs4193)"
FT                   /id="VAR_060510"
FT   VARIANT         78
FT                   /note="R -> RR (in allele DQA1*03:01, allele DQA1*03:02 and
FT                   allele DQA1*03:03)"
FT                   /id="VAR_060511"
FT   VARIANT         81
FT                   /note="P -> R (in allele DQA1*05:02; dbSNP:rs41541412)"
FT                   /id="VAR_060512"
FT   VARIANT         83
FT                   /note="F -> G (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; requires 2
FT                   nucleotide substitutions)"
FT                   /id="VAR_060513"
FT   VARIANT         86
FT                   /note="T -> R (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142333)"
FT                   /id="VAR_033408"
FT   VARIANT         88
FT                   /note="I -> M (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142334)"
FT                   /id="VAR_033409"
FT   VARIANT         91
FT                   /note="L -> A (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; requires 2
FT                   nucleotide substitutions)"
FT                   /id="VAR_060514"
FT   VARIANT         91
FT                   /note="L -> T (in allele DQA1*04:01, allele DQA1*04:02,
FT                   allele DQA1*04:04, allele DQA1*06:01 and allele DQA1*06:02;
FT                   requires 2 nucleotide substitutions)"
FT                   /id="VAR_060515"
FT   VARIANT         97
FT                   /note="S -> I (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,
FT                   allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03,
FT                   allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04,
FT                   allele DQA1*06:01 and allele DQA1*06:02; dbSNP:rs9279910)"
FT                   /id="VAR_060516"
FT   VARIANT         98
FT                   /note="L -> M (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1064944)"
FT                   /id="VAR_060517"
FT   VARIANT         98
FT                   /note="L -> V (in allele DQA1*03:01, allele DQA1*03:02 and
FT                   allele DQA1*03:03; dbSNP:rs1064944)"
FT                   /id="VAR_060518"
FT   VARIANT         101
FT                   /note="R -> C (in allele DQA1*01:07; dbSNP:rs41542116)"
FT                   /id="VAR_060519"
FT   VARIANT         102
FT                   /note="S -> Y (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1129808)"
FT                   /id="VAR_050384"
FT   VARIANT         124
FT                   /note="L -> V (in allele DQA1*05:06; dbSNP:rs41555012)"
FT                   /id="VAR_060520"
FT   VARIANT         129
FT                   /note="I -> T (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,
FT                   allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,
FT                   allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and
FT                   allele DQA1*06:02; dbSNP:rs707952)"
FT                   /id="VAR_050385"
FT   VARIANT         151
FT                   /note="H -> Q (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:04, allele DQA1*01:05 and allele DQA1*01:07;
FT                   dbSNP:rs707950)"
FT                   /id="VAR_050386"
FT   VARIANT         152
FT                   /note="S -> A (in allele DQA1*01:03; dbSNP:rs41547417)"
FT                   /id="VAR_060521"
FT   VARIANT         160
FT                   /note="T -> I (in allele DQA1*04:02; dbSNP:rs41545514)"
FT                   /id="VAR_060522"
FT   VARIANT         161
FT                   /note="S -> I (in allele DQA1*05:08; dbSNP:rs41544114)"
FT                   /id="VAR_060524"
FT   VARIANT         161
FT                   /note="S -> R (in allele DQA1*06:02; dbSNP:rs41552014)"
FT                   /id="VAR_060523"
FT   VARIANT         175
FT                   /note="Y -> H (in allele DQA1*04:04; dbSNP:rs41550317)"
FT                   /id="VAR_060525"
FT   VARIANT         178
FT                   /note="L -> F (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,
FT                   allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,
FT                   allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and
FT                   allele DQA1*06:02; dbSNP:rs707949)"
FT                   /id="VAR_060526"
FT   VARIANT         182
FT                   /note="A -> D (in allele DQA1*03:02 and allele DQA1*03:03;
FT                   dbSNP:rs7990)"
FT                   /id="VAR_060527"
FT   VARIANT         182
FT                   /note="A -> S (in allele DQA1*05:03, allele DQA1*05:06 and
FT                   allele DQA1*05:07; dbSNP:rs41561312)"
FT                   /id="VAR_060528"
FT   VARIANT         183
FT                   /note="E -> D (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,
FT                   allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,
FT                   allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and
FT                   allele DQA1*06:02; dbSNP:rs707963)"
FT                   /id="VAR_060529"
FT   VARIANT         185
FT                   /note="S -> I (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,
FT                   allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,
FT                   allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,
FT                   allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and
FT                   allele DQA1*06:02; dbSNP:rs707962)"
FT                   /id="VAR_060530"
FT   VARIANT         197
FT                   /note="K -> E (in allele DQA1*02:01, allele DQA1*03:01,
FT                   allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,
FT                   allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01 and
FT                   allele DQA1*06:02; dbSNP:rs2308891)"
FT                   /id="VAR_060531"
FT   VARIANT         197
FT                   /note="K -> Q (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05 and
FT                   allele DQA1*01:07; dbSNP:rs2308891)"
FT                   /id="VAR_060532"
FT   VARIANT         209
FT                   /note="A -> T (in allele DQA1*03:01, allele DQA1*03:02 and
FT                   allele DQA1*03:03; dbSNP:rs9272785)"
FT                   /id="VAR_050387"
FT   VARIANT         221
FT                   /note="A -> T (in allele DQA1*01:04; dbSNP:rs35087390)"
FT                   /id="VAR_050388"
FT   VARIANT         229
FT                   /note="V -> M (in allele DQA1*01:02; dbSNP:rs9260)"
FT                   /id="VAR_033411"
FT   VARIANT         230
FT                   /note="G -> C (in allele DQA1*05:07; dbSNP:rs41545416)"
FT                   /id="VAR_060533"
FT   VARIANT         237
FT                   /note="F -> L (in allele DQA1*02:01, allele DQA1*03:01,
FT                   allele DQA1*03:02 and allele DQA1*03:03; dbSNP:rs1048430)"
FT                   /id="VAR_033412"
FT   VARIANT         240
FT                   /note="R -> Q (in allele DQA1*01:01, allele DQA1*01:02,
FT                   allele DQA1*01:03, allele DQA1*01:04 and allele DQA1*01:05;
FT                   dbSNP:rs1048439)"
FT                   /id="VAR_033413"
FT   CONFLICT        11
FT                   /note="A -> S (in Ref. 4; AAA59760)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        23..27
FT                   /note="Missing (in Ref. 16; AAA59754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        91
FT                   /note="L -> H (in Ref. 4; AAA59760)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        107
FT                   /note="A -> P (in Ref. 16; AAA59754)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        156
FT                   /note="G -> D (in Ref. 3; CAA25141)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        213
FT                   /note="E -> D (in Ref. 16; AAA59754)"
FT                   /evidence="ECO:0000305"
FT   STRAND          29..40
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   TURN            41..44
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          45..52
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          55..61
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   TURN            62..65
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          66..71
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   HELIX           72..76
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   HELIX           81..101
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   TURN            102..104
FT                   /evidence="ECO:0007829|PDB:1JK8"
FT   STRAND          113..120
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          124..126
FT                   /evidence="ECO:0007829|PDB:4OZF"
FT   STRAND          128..137
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          143..148
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          151..153
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          166..168
FT                   /evidence="ECO:0007829|PDB:8VSP"
FT   STRAND          170..178
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          186..191
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          195..197
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   STRAND          199..203
FT                   /evidence="ECO:0007829|PDB:6U3M"
FT   HELIX           212..243
FT                   /evidence="ECO:0007829|PDB:8VSP"
SQ   SEQUENCE   254 AA;  27805 MW;  84E12B5A80E2A028 CRC64;
     MILNKALMLG ALALTTVMSP CGGEDIVADH VASYGVNLYQ SYGPSGQYTH EFDGDEQFYV
     DLGRKETVWC LPVLRQFRFD PQFALTNIAV LKHNLNSLIK RSNSTAATNE VPEVTVFSKS
     PVTLGQPNIL ICLVDNIFPP VVNITWLSNG HSVTEGVSET SFLSKSDHSF FKISYLTLLP
     SAEESYDCKV EHWGLDKPLL KHWEPEIPAP MSELTETVVC ALGLSVGLVG IVVGTVFIIR
     GLRSVGASRH QGPL
//
